Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
In the final episode of Season 2, we look at the future of healthcare in Central Europe and the Baltics, a diverse region that covers almost one third of EU countries.
Tuba Atahan, Managing Director, and Laura Saar, Market Access Director, for Central Europe and Baltics delve into the current barriers to healthcare access in the region – such as the growing disparity in multiple myeloma care – and discuss innovative solutions that will help close the gap.
This recording was organised and funded by Johnson & Johnson
November 2024
CP-485355 | CP-485428
Hosted on Acast. See acast.com/privacy for more information.